openPR Logo
Press release

Current developments in Neurodegenerative Treatments

07-03-2012 10:12 PM CET | Health & Medicine

Press release from: SMi Group

The central nervous system is a fundamental part of the human body's response system, creating a massive range of reactions, targets, and in turn, diseases. With increasing average life expectancy, this wide range of disorders (from Alzheimer’s, to Parkinson’s, MS, dementia and depression), is becoming increasingly widespread in the population creating an ever greater need for new treatments and therapies.

Clinical trials are still an important area of discussion, with increasing efficiency in R&D and clinical trials as an essential part of the pharma industry. Clinical trials in the CNS industry must therefore operate a minefield of varying regulations and logistical difficulties, in order to develop a drug from discovery to market.

Johan Luthman, Senior Programme Leader Merck & Co. will speak at SMi’s Clinical Trials in CNS event held in London on the 5th & 6th November on the new opportunities to follow brain function and dysfunction a research on Alzheimers’s disease. He will discuss the critical AD biomarker validation and qualification work done via public-private pre competitive partnerships and detecting very early stages of AD pathology and following the disease progression with new technologies.

Register today to hear about the current development in neurodegenerative treatments from top pharma companies and academics. For further information and to register visit http://www.smi-online.co.uk/goto/clinicaltrials-research14.asp and quote OPENPR. Or contact Ninica Hussain on tel +44 0 207 827 6186 or email nhussain@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group Ltd
2nd Floor South, Harling House 47-51 Great Suffolk Street,
London, SE1 0BS

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Current developments in Neurodegenerative Treatments here

News-ID: 227336 • Views: 2577

More Releases from SMi Group

Invitation from Conference Chairman, Jeremy Heath, Sutton & East Surrey Water fo …
Building on the success of previous years, SMi’s 11th Annual Smart Water Systems Conference will offer peer-to-peer networking with leaders in the Smart Water Market give delegates in depth knowledge on the requirements you need to build an efficient Advanced Metering Infrastructure. The conference will convene on 4th and 5th April 2022 in London, UK, interested parties can register at http://www.smart-water-systems.com/PR2openPR - register by 31st January 2022 to save £200. The aim
New speakers from Abbvie, GSK, Scripps Research and Engitix Therapeutics join 3D …
SMi Group reports: new speakers from Abbvie, GSK, Scripps Research and Engitix Therapeutics join the 5th Annual 3D Cell Culture Conference in February 2022 Only four weeks to go until the 5th Annual 3D Cell Culture will now take place as a ‘Virtual Conference’ with online access only on 9th and 10th February 2022. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to
Registration is now open for Highly Potent Active Pharmaceutical Ingredients 202 …
SMi Group reports: The 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference is set to return in May 2022 with a focus on key regulatory updates, and leading case studies from leading pharmaceutical and biotechnology companies. SMi Group is delighted to announce the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference, taking place on the 9th and 10th May 2022 in London, UK. The 2022 Conference theme is ensuring product quality
Book to attend the Parallel Trade conference before midnight Friday 28th January …
SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade. The 2022 event will be more significant than ever before due to the transition period after Brexit coming to an

All 5 Releases


More Releases for Clinical

Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are